Legal entity responsible for the study: Department of surgery, oncology and gastroenterology, University of Padova. Funding: drug supply and financial support from Merck Kga. This is an ASCO Meeting ...

that he was diagnosed with cancer. Arnold said in an Instagram reel that he "got sick a couple weeks ago" and was checked out at a hospital. The prognosis was heavy: He was told he has Stage 4 ...

Use of nasal tanning sprays that are linked to skin cancer and other health problems is on the rise, warns The Chartered Trading Standards Institute (CTSI). The unregulated nasal tanning sprays ...

The expert urged people to follow his advice in order to catch skin cancer symptoms sooner rather than later. Skin cancer affects over 170,000 people in the UK each year, making it one of the most ...

The then-40-year-old, who didn’t smoke and considered herself healthy, had surgery and chemotherapy, but her cancer came back ... worst until she discovered a first-of-its-kind clinical trial ...

Direct deposit changes will now only take one business day to complete. There are new anti-fraud measures in place for applications and account changes that happen over the phone. President Trump ...

"She says, 'I haven't showered in days ... cancer back in 2013 and underwent a radical hysterectomy. Then in 2017, Camille had surgery to remove Squamous Cell Carcinoma, a type of skin cancer.

A California man battling lung cancer is unable to get treatment he planned for after being denied by his health insurance company Cigna Healthcare. Daron Wells, a 59-year-old man with stage 4 ...

The politician took to social media on Thursday to share the news with her followers revealing she is in stage 4 of a cancer known as ... "I know there are difficult days ahead, but I'm facing ...

Ms Murray underwent surgery again the following month - this time to remove a large patch of skin on her arm including some glands to ensure all the cancer cells were destroyed. The procedure ...

In its 15th year, Verastem Oncology has gained its first FDA approval, winning an accelerated nod for the combination treatment of avutometinib and defactinib for a rare form of ovarian cancer.